Inhibition of Epstein-Barr virus-associated nuclear antigen (EBNA) induction by (2',5')oligoadenylate and the cordycepin analog: mechanism of action for inhibition of EBV-induced transformation.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000956:Antigens, Viral / Q000235:genetics*; D002472:Cell Transformation, Viral / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects; D003839:Deoxyadenosines / Q000031:analogs & derivatives; D019309:Epstein-Barr Virus Nuclear Antigens; D005786:Gene Expression Regulation / Q000187:drug effects; D004854:Herpesvirus 4, Human; D007370:Interferon Type I / Q000494:pharmacology; D009841:Oligonucleotides / Q000494:pharmacology*; D009843:Oligoribonucleotides / Q000494:pharmacology*; D014176:Protein Biosynthesis / Q000187:drug effects; D014158:Transcription, Genetic / Q000187:drug effects
D000227:Adenine Nucleotides; D000956:Antigens, Viral; D003839:Deoxyadenosines; D019309:Epstein-Barr Virus Nuclear Antigens; D007370:Interferon Type I; D009841:Oligonucleotides; D009843:Oligoribonucleotides; C023505:2',5'-oligoadenylate